iRhythm Holdings, Inc. (IRTC) News
Follow iRhythm Holdings, Inc. (IRTC) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 17 public stories across 13 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
iRhythm Reports Q3 Revenue Below Consensus, Delays Zio MCT FDA Submission
iRhythm reported third-quarter 2026 revenue of $221.6 million, below analyst consensus, and said Zio AT sales were flat year over year. The company delayed its next-generation Zio MCT FDA submission until 2027, citing po
EQUITY | Nov 06, 2026, 11:03 PM UTC
L
iRhythm 3Q 2026: Revenue $221.59M, EPS ($0.9) — 10-Q Summary
iRhythm’s third-quarter revenue rose 15% year over year on increased demand and service volume, while its net loss widened, driven largely by litigation settlements, including the $50.0 million Baxter settlement. Improve
EARNINGS | Nov 05, 2026, 10:32 PM UTC
M
iRhythm Reports Q3 Revenue of $221.6 Million, Up 14.9%
iRhythm reported Q3 2026 revenue of $221.6 million, up 14.9% year over year. It expects 2026 revenue of $890 million–$895 million and an adjusted EBITDA margin of 15.5%–16.0%, including approximately $16 million of expec
EQUITY | Nov 05, 2026, 09:09 PM UTC
M
iRhythm Holdings Reports Third-Quarter 2026 Financial Results
iRhythm Holdings reported results for the three months ended September 30, 2026.
EQUITY | Nov 05, 2026, 09:08 PM UTC
M
iRhythm Holdings to Report Third-Quarter 2026 Results November 5
iRhythm Holdings said it will report its third-quarter 2026 financial results on November 5, 2026.
EQUITY | Oct 15, 2026, 08:05 PM UTC
M
iRhythm Acquires VitalConnect
iRhythm has completed its acquisition of VitalConnect, aiming to expand its cardiac monitoring platform across ambulatory, inpatient, and hospital-to-home care.
EQUITY | Oct 05, 2026, 01:05 PM UTC
L
iRhythm says Vital Connect acquisition to close in early October
iRhythm said HSR clearance expired and it expects to complete the Vital Connect acquisition in early October 2026.
MNA | Sep 22, 2026, 09:03 PM UTC
M
VitalConnect acquisition expands IRTC’s full MCT market access
IRTC’s acquisition of VitalConnect expands its product portfolio to address the MCT market, using differentiated technology and a larger sales force for nationwide growth.
MNA | Sep 09, 2026, 02:29 PM UTC
M
VitalConnect acquisition: IRTC targets 15% EBITDA margin by 2027
IRTC said its VitalConnect acquisition is meant to fully address the MCT market, leveraging differentiated technology and expanding its product portfolio. The company reiterated a 15% EBITDA margin goal for 2027 and cont
MNA | Sep 09, 2026, 01:53 PM UTC
L
iRhythm Holdings to participate in Wells Fargo 21st healthcare conference
iRhythm Holdings will participate in Wells Fargo 21st Annual Healthcare Conference.
EQUITY | Aug 26, 2026, 08:07 PM UTC
L
IRTC - iRhythm Holdings to Participate in Wells Fargo 21st Annual Healthcare Conference
IRTC - iRhythm Holdings to Participate in Wells Fargo 21st Annual Healthcare Conference
EQUITY | Aug 26, 2026, 08:05 PM UTC
L
iRhythm Technologies insider fiduciary-duty breach claim raised
TradeXchange Newsdesk flags a question about whether iRhythm Technologies, Inc. insiders breached fiduciary duties to shareholders, citing no specific details, figures, or timeline in the alert.
REGULATION | Aug 17, 2026, 07:35 AM UTC
L
iRhythm Combines Strong Performance with VitalConnect Buy to Expand Remote Cardiac Care
Digital healthcare company iRhythm Holdings, Inc. (NASDAQ: IRTC ) on Thursday agreed to acquire Vital Connect, Inc., a privately held developer of wearable biosensor technology. iRhythm Agrees To Acquire VitalConnect for
EARNINGS | Aug 07, 2026, 02:47 PM UTC
L
iRhythm Holdings Raises FY2026 Sales Guidance from $875.000M-$885.000M to $880.000M-$890.000M vs $881.129M Est
iRhythm Holdings (NASDAQ: IRTC ) raises FY2026 sales outlook from $875.000 million-$885.000 million to $880.000 million-$890.000 million vs $881.129 million estimate.
EARNINGS | Aug 06, 2026, 08:14 PM UTC
H
WBLR Updates Analyst Conviction List
Adds and removes stocks from conviction list
EQUITY | Aug 03, 2026, 11:59 AM UTC
L
iRhythm Technologies Insiders Face Fiduciary Probe
iRhythm insiders probed for fiduciary duty breach
EQUITY | Jul 29, 2026, 03:00 PM UTC
L
Did iRhythm Technologies, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Did iRhythm Technologies, Inc. Insiders Breach their Fi
EQUITY | Jul 03, 2026, 04:38 PM UTC